Protein Name: | Alpha-1A adrenergic receptor (P35348) |
---|---|
Gene Name: | ADRA1A |
Description: | |
PDB ID: | |
Protein Family: | PF00001, PS00237 |
Protein Category: | Membrane Receptors |
This panel provides drug-protein interaction and their ADRs along with references
Interacting Drugs | Toxicity | Mechanism | Reference |
---|---|---|---|
Exemestane | Depression | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Gabapentin | Anxiety | Significant adverse effects may occur through the interaction of the antidepressants with other receptors believed not to be related to the therapeutic action@ most importantly the muscarinic acetylcholine receptor (M)@ the histamine-1 (H1) receptor and the alpha-1 (alpha 1) adrenergic receptor@leading to anxiety. [ ADR Type 2 ] | Cell-mediated side effects of psychopharmacological treatment |
Gabapentin | Nausea | Significant adverse effects may occur through the interaction of the antidepressants with other receptors believed not to be related to the therapeutic action@ most importantly the muscarinic acetylcholine receptor (M)@ the histamine-1 (H1) receptor and the alpha-1 (alpha 1) adrenergic receptor@leading to nausea. [ ADR Type 2 ] | Cell-mediated side effects of psychopharmacological treatment |
Gabapentin | Sleep Disturbances | Significant adverse effects may occur through the interaction of the antidepressants with other receptors believed not to be related to the therapeutic action@ most importantly the muscarinic acetylcholine receptor (M)@ the histamine-1 (H1) receptor and the alpha-1 (alpha 1) adrenergic receptor@leading to sleep disturbances. [ ADR Type 2 ] | Cell-mediated side effects of psychopharmacological treatment |
Medroxyprogesterone | Amenorrhoea | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Medroxyprogesterone | Cushingoid | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Medrysone | Electrolyte Imbalance | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Medrysone | Menstrual Disorder | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Sertraline | Ataxia | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides information on drug category